The efficacy of tea and its catechins in deactivating the Omicron subvariant.
Lindis Blood Care Announces Successful Financing for its Tumor-Cell-Removal Medical Device, CATUVAB® – Biotech Investments
EQS-News: Lindis Blood Care GmbH / Key word(s): Financing Lindis Blood Care Announces Successful Financing for its Tumor-Cell-Removal Medical Device, CATUVAB® 12.12.2024 / 10:00 CET/CEST